Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
26.35
-0.01 (-0.04%)
At close: Feb 27, 2026, 4:00 PM EST
26.33
-0.02 (-0.08%)
After-hours: Feb 27, 2026, 7:14 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Research and Development of Precision Immunology-Based Therapies
5.00M50.00M
Research and Development of Precision Immunology-Based Therapies Growth
-90.00%-
Total
5.00M50.00M
Total Growth
-90.00%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M50.00M
United States Growth
-90.00%-
Total
5.00M50.00M
Total Growth
-90.00%-
Source: S&P Global Market Intelligence.